SCHEMBL24029043

SCHEMBL24029043

c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccc(-c5ccc(N(c6ccc(-c7ccccc7)cc6)c6ccc(-c7ccc(-c8ccc9cc(N(c%10ccccc%10)c%10ccc(-c%11ccc(N(c%12ccccc%12)c%12ccc%13ccccc%13c%12)cc%11)cc%10)ccc9c8)cc7)cc6)cc5)cc4)cc3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.50
ESR2 Q92731 3/20 0.50
HSD17B1 P14061 1/20 0.47
HSD17B2 P37059 1/20 0.47
ACMSD Q8TDX5 1/20 0.45
CYP17A1 P05093 1/20 0.44
CYP19A1 P11511 1/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
ALOX5 P09917 2/20 0.44
BACE1 P56817 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
CYP1A1 P04798 1/20 0.42
CYP1B1 Q16678 1/20 0.42
GSTP1 P09211 1/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14263582 1.00 ESR1 (0.50) ESR1ESR2HSD17B1HSD17B2ACMSD
SCHEMBL19998766 1.00 ESR1 (0.50) ESR1ESR2HSD17B1HSD17B2ACMSD
SCHEMBL14263647 1.00 ESR1 (0.50) ESR1ESR2HSD17B1HSD17B2ACMSD
SCHEMBL20313408 0.98 ESR1 (0.50) ESR1ESR2HSD17B1HSD17B2ACMSD
SCHEMBL9888966 0.98 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2ACMSD
SCHEMBL23095516 0.98 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2ACMSD
SCHEMBL23765487 0.98 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2ACMSD
SCHEMBL18941678 0.98 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2ACMSD
SCHEMBL24153962 0.98 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2ACMSD
SCHEMBL24686644 0.98 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2ACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230313034-A1 METHOD OF PREPARING METAL OXIDE COMPOSITION, LIGHT-EMITTING DEVICE USING METAL OXIDE COMPOSITION PREPARED THEREBY, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-05 US disclosed
US-20230240142-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed
US-20230180505-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-08 US disclosed
US-20230133575-A1 LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND SAMSUNG DISPLAY CO LTD (KR) 2023-05-04 US disclosed
US-20220199903-A1 LIGHT-EMITTING DEVICE AND AN ELECTRONIC APPARATUS INCLUDING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-06-23 US disclosed
US-20210367156-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-11-25 US disclosed
US-20210359215-A1 COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210359215-A1 COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, SIRT1 ESR1 81/4885ESR2 291/4885HSD17B1 2202/4885
US-20230240142-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, CCNE2, NCAPH ESR1 25/4885ESR2 223/4885HSD17B1 1774/4885
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, LAGE3, NQO1 ESR1 7/4885ESR2 191/4885HSD17B1 1318/4885
US-20230133575-A1 LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND LAGE3, LEF1, ELP1 ESR1 197/4885ESR2 505/4885HSD17B1 1374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.